Articles with public access mandates - Douglas FearonLearn more
OverallNIHCancer Research UKWellcomeMRCNIHRVersus Arthritis, UKDoDDFGBBSRCEuropean CommissionPancreatic Cancer Action Network, USAV Foundation, USADamon Runyon Cancer Research FoundationNSFNHMRCSwedish Research CouncilKWFGovernment of ItalyHFSPSusan G. KomenSNSFEMBLAcademy of FinlandBHFEPSRCESRCNational Centre for the Replacement, Refinement and Reduction of Animals in Research, UKWorldwide Cancer Research, UKState of CalifoniaSCLUK Research & InnovationPancreatic Cancer, UK
Not available anywhere: 5
Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein–α
M Kraman, PJ Bambrough, JN Arnold, EW Roberts, L Magiera, JO Jones, ...
Science 330 (6005), 827-830, 2010
Mandates: US National Institutes of Health, Swedish Research Council, Cancer Research UK
Connecting the metabolic and immune responses to cancer
TR Flint, DT Fearon, T Janowitz
Trends in molecular medicine 23 (5), 451-464, 2017
Mandates: Cancer Research UK, National Institute for Health Research, UK, Wellcome Trust
OP0242 Selective Deletion of Fap Expressing Cells Attenuates Synovial Inflammation and Protects against Inflammatory Bone Changes
AP Croft, J Campos, M MacKenzie, A Filer, D Fearon, G Desanti, F Barone, ...
Annals of the Rheumatic Diseases 75 (Suppl 2), 149-150, 2016
Mandates: Versus Arthritis, UK, Cancer Research UK, Wellcome Trust
A3. 11 Selective deletion of cells expressing fibroblast activation protein attenuates synovial inflammation
AP Croft, J Campos, M MacKenzie, A Filer, DT Fearon, F Barone, ...
Annals of the Rheumatic Diseases 75 (Suppl 1), A36-A37, 2016
Mandates: UK Research & Innovation
Demonstration of Receptor Function of Membrane Proteins by Selection and Immobilization with Monoclonal Antibodies
JJ Weis, DT Fearon
Hybridoma Technology in the Biosciences and Medicine, 207-221, 2013
Mandates: US National Institutes of Health
Available somewhere: 34
A framework for advancing our understanding of cancer-associated fibroblasts
E Sahai, I Astsaturov, E Cukierman, DG DeNardo, M Egeblad, RM Evans, ...
Nature Reviews Cancer 20 (3), 174-186, 2020
Mandates: US Department of Defense, US National Institutes of Health, German Research …
T cell exclusion, immune privilege, and the tumor microenvironment
JA Joyce, DT Fearon
Science 348 (6230), 74-80, 2015
Mandates: US National Institutes of Health, Cancer Research UK, Worldwide Cancer …
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
D Öhlund, A Handly-Santana, G Biffi, E Elyada, AS Almeida, ...
Journal of Experimental Medicine 214 (3), 579-596, 2017
Mandates: US Department of Defense, US National Institutes of Health, Swedish Research …
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer
C Feig, JO Jones, M Kraman, RJB Wells, A Deonarine, DS Chan, ...
Proceedings of the National Academy of Sciences 110 (50), 20212-20217, 2013
Mandates: Cancer Research UK, UK Medical Research Council, Wellcome Trust
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
J Albrengues, MA Shields, D Ng, CG Park, A Ambrico, ME Poindexter, ...
Science 361 (6409), eaao4227, 2018
Mandates: US Department of Defense, US National Institutes of Health, German Research …
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ...
Nature 551 (7681), 512-516, 2017
Mandates: US National Science Foundation, US National Institutes of Health, Pancreatic …
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
K Yamamoto, A Venida, J Yano, DE Biancur, M Kakiuchi, S Gupta, ...
Nature 581 (7806), 100-105, 2020
Mandates: US National Science Foundation, US National Institutes of Health, Pancreatic …
Distinct fibroblast subsets drive inflammation and damage in arthritis
AP Croft, J Campos, K Jansen, JD Turner, J Marshall, M Attar, L Savary, ...
Nature 570 (7760), 246-251, 2019
Mandates: US National Institutes of Health, German Research Foundation, Versus …
Classification of current anticancer immunotherapies
L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ...
Oncotarget 5 (24), 12472, 2014
Mandates: US National Institutes of Health, National Health and Medical Research …
Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia
EW Roberts, A Deonarine, JO Jones, AE Denton, C Feig, SK Lyons, ...
Journal of Experimental Medicine 210 (6), 1137-1151, 2013
Mandates: Cancer Research UK, UK Medical Research Council, Wellcome Trust
Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics
JG Crompton, M Sukumar, R Roychoudhuri, D Clever, A Gros, RL Eil, ...
Cancer research 75 (2), 296-305, 2015
Mandates: US National Institutes of Health, Cancer Research UK, Wellcome Trust
Tumor-induced IL-6 reprograms host metabolism to suppress anti-tumor immunity
TR Flint, T Janowitz, CM Connell, EW Roberts, AE Denton, AP Coll, ...
Cell metabolism 24 (5), 672-684, 2016
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
The carcinoma-associated fibroblast expressing fibroblast activation protein and escape from immune surveillance
DT Fearon
Cancer immunology research 2 (3), 187-193, 2014
Mandates: Cancer Research UK, UK Medical Research Council
Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases
A Pommier, N Anaparthy, N Memos, ZL Kelley, A Gouronnec, R Yan, ...
Science 360 (6394), eaao4908, 2018
Mandates: US National Institutes of Health
Secondary replicative function of CD8+ T cells that had developed an effector phenotype
O Bannard, M Kraman, DT Fearon
Science 323 (5913), 505-509, 2009
Mandates: Swiss National Science Foundation
Publication and funding information is determined automatically by a computer program